Adjuvant Immunotherapy in Patients with Resected Gastric and Oesophagogastric Junction Cancer Following Preoperative Chemotherapy with High Risk for Recurrence (ypn+ And/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE Study.
Annals of oncology official journal of the European Society for Medical Oncology（2024）
关键词
gastric cancer,esophagogastric junction cancer,perioperative,immunotherapy,chemotherapy
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要